Navigation Links
Chiasma Receives Orphan Drug Designation From the FDA for Octreolin™ for the Oral Treatment of Acromegaly
Date:6/27/2010

NEW YORK and JERUSALEM, June 28 /PRNewswire/ -- Chiasma, Inc., a privately held biopharma company, announced that the Food and Drug Administration (FDA) has granted orphan drug designation for Chiasma's investigational new drug, Octreolin, an oral form of octreotide acetate that uses the Company's proprietary Transient Permeability Enhancer (TPE) technology for the oral treatment of acromegaly, a hormonal disorder that results from an excess of growth hormone.

If a New Drug Application (NDA) is approved, Octreolin should qualify for seven years of market exclusivity, potential tax credits, and a waiver of the prescription drug user fee for the marketing application.

Chiasma has successfully completed a Phase I clinical study evaluating the safety and pharmacokinetics (PK) of Octreolin, which demonstrated a PK profile similar to that of subcutaneously injected octreotide acetate.  In addition, no serious adverse safety events were reported for Octreolin. The Company intends to initiate a pivotal (Phase 3) trial by the end of the year for Octreolin in acromegaly.

Chiasma will submit an application for Orphan Medicinal Product Designation to the European Medicines Agency (EMA) shortly. The Company intends to submit an NDA using the "505(b)(2) regulatory pathway" in the United States and its equivalent, the "Hybrid Application," in Europe.

Octreolin would provide patients with the benefit of an oral alternative to the currently approved subcutaneous and intramuscular injections. The pool of patients eligible for Octreolin treatment for acromegaly is estimated to be between 10,000 and 15,000 in the U.S. and an equal number in Eur
'/>"/>

SOURCE Chiasma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
4. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
5. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
6. IsoTis Receives FDA Clearance for Accell Family of Products
7. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
10. XTL Receives Staff Letter From NASDAQ
11. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Cambridge Semantics, the leading provider of ... that 2014 was a record-breaking year across the board for ... Anzo Smart Data Platform and our Smart Data solutions, our ... diverse data which led to record growth for the company ...
(Date:1/22/2015)... 2015 Protocol Networks brings independent technology ... of brand-neutral, independent consultants, Protocol Networks has recently announced ... over the years, his company has attracted several clients ... Plainfield, as well as others. With the success of ...
(Date:1/22/2015)... Pipette.com has added the Eppendorf Centrifuge ... of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 R ... R and receive the following:, ,     Free ... Eppendorf Reference 2 ,     3 Free boxes ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited ... seminar on probiotics in San Diego, CA. , The ... for health care professionals. This year’s pre-conference seminar was held ... health. Dr. Leyer spoke about the emerging topics and science ...
Breaking Biology Technology:Cambridge Semantics Announces Record Results for 2014 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2
... , , , , For automated purification of genomic and mitochondrial , ... , Format: , ... QIAamp DNA Blood MDX Protocol, , ... Fresh or frozen whole blood (with common anticoagulants , such as citrate and EDTA) ...
... , , , , , , , For fast and efficient ... , , , ... Storage and Stability , Technical ... Product Use Limitations , Product Warranty and Satisfaction Guarantee ...
... , , , , ... to guarantee you optimal performance in your molecular ... agreements to fit your application , requirements ... applications, to fully integrated automation systems for functional genomics, , ...
Cached Biology Technology:QIAamp DNA Blood BioRobot MDx Kit 2QIAGEN Multiplex PCR Handbook 2QIAGEN Multiplex PCR Handbook 3QIAGEN Multiplex PCR Handbook 4QIAGEN Multiplex PCR Handbook 5QIAGEN Multiplex PCR Handbook 6QIAGEN Multiplex PCR Handbook 7QIAGEN Multiplex PCR Handbook 8QIAGEN Multiplex PCR Handbook 9QIAGEN Multiplex PCR Handbook 10QIAGEN Multiplex PCR Handbook 11QIAGEN Multiplex PCR Handbook 12QIAGEN Multiplex PCR Handbook 13QIAGEN Multiplex PCR Handbook 14QIAGEN Multiplex PCR Handbook 15QIAGEN Multiplex PCR Handbook 16QIAGEN Multiplex PCR Handbook 17QIAGEN Multiplex PCR Handbook 18QIAGEN Multiplex PCR Handbook 19QIAGEN Multiplex PCR Handbook 20QIAGEN Multiplex PCR Handbook 21QIAGEN Multiplex PCR Handbook 22QIAGEN Multiplex PCR Handbook 23QIAGEN Multiplex PCR Handbook 24QIAGEN Multiplex PCR Handbook 25QIAGEN Multiplex PCR Handbook 26QIAGEN Multiplex PCR Handbook 27QIAGEN Multiplex PCR Handbook 28QIAGEN Multiplex PCR Handbook 29QIAGEN Multiplex PCR Handbook 30QIAGEN Multiplex PCR Handbook 31QIAGEN Multiplex PCR Handbook 32QIAGEN Multiplex PCR Handbook 33QIAGEN Instrument Service insist on the best in service and support 2QIAGEN Instrument Service insist on the best in service and support 3
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... of the "Global Wearable Technologies Market and ... Overview, Trends and Forecast 2014-2020" report to ... are smart devices that can be worn on ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
(Date:12/22/2014)... Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce market, ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID booth January ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... annual Wiley Prize in Biomedical Sciences was awarded to ... how cells sense and respond to low oxygen conditions. ... William G. Kaelin Jr., M.D., of the Dana-Farber Cancer ... and Steven McKnight, Ph.D., of the University of Texas ...
... animals have played such a central role in human history ... reveals that a horse,s gait, an attribute central to its ... by humans across the world. The team, led by ... explored the distribution of a mutation in the DMRT3 gene ...
... bioengineer has received a four-year, $1.4 million National Institutes ... shore up arterial walls following angioplasty and stenting procedures ... Arlington associate professor of bioengineering, said the research looks ... arteries and blood vessels that are blocked., "We have ...
Cached Biology News:Horse gaits controlled by genetic mutation spread by humans, new study reveals 2UT Arlington bioengineer to create new nanoparticle system to shore up arterial walls 2
... gel Software converts any scanner into a ... options and features, the basic operation simply ... PCX, BMP, etc.) into pixel density / ... Turn your scanner into ...
Anti-Conjugated Quinaldic Acid...
... stain kits are optimized for use ... Dodeca stainers. This silver stain kit ... in polyacrylamide gels and are mass ... concentrate, silver reagent concentrate, background reducer ...
The AVR9-8 stream-select valve is a 9-port, 8-position valve for use with the BioLogic DuoFlow system. This valve is used for high-pressure stream selection....
Biology Products: